Actively Recruiting
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
Led by University of California, Davis · Updated on 2025-12-05
25
Participants Needed
1
Research Sites
309 weeks
Total Duration
On this page
Sponsors
U
University of California, Davis
Lead Sponsor
U
University of California, San Francisco
Collaborating Sponsor
AI-Summary
What this Trial Is About
Currently a multiport robotic surgery platform (Intuitive Xi) is widely available and used for colorectal surgery indications. A Single port platform (Intuitive SP) is FDA approved for Head and Neck and Urology but has not been widely used in colorectal surgery. This study seeks to evaluate the safe and effective use of the SP platform for colorectal surgery indications.
CONDITIONS
Official Title
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 years or older
- Female participants must have a negative urine pregnancy test and not be lactating or not be of childbearing potential for at least 3 months prior
- Documentation of a colorectal diagnosis requiring surgery with plans for robotic operation
- For transanal procedures, eligible patients have specific early-stage rectal tumors distal to 15 cm from the anal verge
- Participants must be in good general health based on medical history and physical exam
- Ability and willingness to provide informed consent
- Willingness to comply with study protocol and complete required measures
- Stable residence and telephone access
You will not qualify if you...
- Children under 18 years old
- Pregnant or breastfeeding females
- Patients classified as American Society of Anesthesia Class IV or V
- History of significant kidney, liver, neurological, heart, or chronic lung disease that prevents participation
- Advanced (Stage IV) cancer
- Prior neo-adjuvant chemotherapy or radiation therapy
- Emergency surgery requirement
- Inability to fully understand or consent to the study
- Unwillingness to be available for follow-up assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UC Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
A
Ankit Sarin, MD
CONTACT
P
Pallavi Vaidya, BPharm
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here